Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
For-Robin Logo
For-Robin Growth Score
36
CB Rank
412976
Heat Score
1
For-Robin Therapeutics is an antibody immunotherapy company.
Founded
obfuscation
PrivateGrant New York, New York, United States1-10 www.for-robin.com/
Biotechnology
Therapeutics
Overview

For-Robin
Total Funding
obfuscation
Growth Score
36
Heat Score
1

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score36
-1 pts
in past quarter
Heat Score 1
-6 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About For-Robin

CB Rank
412976
For-Robin Therapeutics is an antibody immunotherapy company.
Founded
obfuscation
PrivateGrant New York, New York, United States1-10 www.for-robin.com/
Biotechnology
Therapeutics

Funding Rounds

Grant
OBF
in
obfuscation

Key People

Details

Legal Name For-Robin, Inc.
Operating Status Active
Company Type For Profit
Founders  Kate Rittenhouse-Olson
About the Company

For-Robin Therapeutics is an antibody immunotherapy company. The company name is in honor of Robin Quataert, the Founder’s sister, who died at age 31 of estrogen and progesterone receptor negative breast cancer.

For-Robin’s primary mission is treating breast cancer patients. Our proprietary technology (the monoclonal antibody JAA-F11 and

humanized variants of it) targets all breast cancer cell subtypes including triple negative breast cancer which currently has no targeted therapy.

Phone Number 7168293601
Contact Email jolson@buffalo.edu
Diversity Spotlight 
Women Founded
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Antibody Immunotherapy Products
Antibody-based immunotherapy treatments developed to target cancer cells, intended for clinical use in cancer therapy.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - For-Robin Logo
Grant - For-Robin
—
obfuscation
— Grant
obfuscation
Grant - For-Robin Logo
Grant - For-Robin
—
obfuscation
— Grant
obfuscation
Grant - For-Robin Logo
Grant - For-Robin
—
obfuscation
— Grant
obfuscation
Grant - For-Robin Logo
Grant - For-Robin
—
obfuscation
— Grant
obfuscation
Grant - For-Robin Logo
Grant - For-Robin
—
obfuscation
— Grant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - For-Robin Logo
Grant - For-Robin
—
obfuscation
— Grant
obfuscation
Grant - For-Robin Logo
Grant - For-Robin
—
obfuscation
— Grant
obfuscation
Grant - For-Robin Logo
Grant - For-Robin
—
obfuscation
— Grant
obfuscation
Grant - For-Robin Logo
Grant - For-Robin
—
obfuscation
— Grant
obfuscation
Grant - For-Robin Logo
Grant - For-Robin
—
obfuscation
— Grant

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2

Employee Profiles

News

News and Press

News•Mar 5, 2016
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$63.9KThis year, For-Robin is projected to spend $63.9K on IT, according to Aberdeen.

Active Website Tech Count

4For-Robin is actively using 4 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Euro.
Sub-Organizations
Frequently Asked Questions

Where is For-Robin's headquarters? For-Robin is located in New York, New York, United States.When was the last funding round for For-Robin? For-Robin closed its last funding round on
obfuscation
from a Grant round.Who are For-Robin's competitors? Alternatives and possible competitors to For-Robin may include AbbVie, AstraZeneca, and  Amgen.How much funding has For-Robin raised to date? For-Robin has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3237dbc 1)
|